Literature DB >> 16210858

Rheumatoid factors: good or bad for you?

Urszula M Nowak1, Marianna M Newkirk.   

Abstract

BACKGROUND: Rheumatoid factors (RFs) are autoantibodies associated with rheumatoid arthritis. They can be detected in normal individuals, although transiently. This dichotomy has led to questions about the origins and types of RFs. Recently it has been shown that B cells that produce RFs only do so when activated by two signals, one from engagement of the B-cell receptor and the other from recognition of a pathogen-associated molecular pattern through a Toll-like receptor (TLR). These autoantibodies thus link the innate and acquired immune responses.
OBJECTIVE: Through a review of the literature, an examination of the current knowledge of RF induction is presented. The focus is on a discussion of a beneficial or detrimental role for RFs in normal individuals and in those with chronic disease.
RESULTS: What makes RF 'good' in some cases and 'bad' in others may reflect the type of RF produced. Low-affinity polyreactive IgM RFs are probably beneficial as they aid in the clearance of immune complexes that are more efficiently cleared, and the RF B cell can act as an antigen-presenting cell and stimulate host defense. However, large amounts of high-affinity RFs found in patients with chronic disease may be harmful by participation in a vicious cycle of autoantibody production by stimulation of self lymphocytes, and/or deposition in blood vessels thus causing vasculitis.
CONCLUSIONS: Whether RFs are beneficial or detrimental depends on the context in which they are expressed, the type and amount of RF produced, whether the response is perpetuated by TLR ligation and whether other cells are stimulated either directly or indirectly by RF-positive B cells. (c) 2005 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210858     DOI: 10.1159/000088794

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Rheumatoid factor induction in murine models of liver injury.

Authors:  U Nowak; K Gill; E Skamene; M M Newkirk
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  IgM, IgG, and IgA rheumatoid factors in pigeon hypersensitivity pneumonitis.

Authors:  Mariana Tellez Araiza; Diana E Aguilar León; Virginia Novelo Retana; Erasmo Martínez-Cordero
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Cross-linking of IgGs bound on circulating neutrophils leads to an activation of endothelial cells: possible role of rheumatoid factors in rheumatoid arthritis-associated vascular dysfunction.

Authors:  Emmanuelle Rollet-Labelle; Myriam Vaillancourt; Louis Marois; Marianna M Newkirk; Patrice E Poubelle; Paul H Naccache
Journal:  J Inflamm (Lond)       Date:  2013-07-31       Impact factor: 4.981

4.  Autoimmune and immunoserological markers of COVID-19 pneumonia: Can they help in the assessment of disease severity.

Authors:  Mihailo I Stjepanovic; Maja R Stojanovic; Sanja Stankovic; Jelena Cvejic; Sanja Dimic-Janjic; Spasoje Popevic; Ivana Buha; Slobodan Belic; Natasa Djurdjevic; Mirjana M Stjepanovic; Dragana Jovanovic; Milica Stojkovic-Laloševic; Ivan Soldatovic; Branka Bonaci-Nikolic; Rada Miskovic
Journal:  Front Med (Lausanne)       Date:  2022-08-29

5.  Anticitrullinated protein/peptide antibodies and rheumatoid factors: two distinct autoantibody systems.

Authors:  Guido Valesini; Cristiano Alessandri
Journal:  Arthritis Res Ther       Date:  2009-09-14       Impact factor: 5.156

6.  Prevalence and Characteristics of Rheumatoid-Associated Autoantibodies in Patients with COVID-19.

Authors:  Chen Xu; Junli Fan; Yi Luo; Ziwu Zhao; Peng Tang; Gui Yang; Yunbao Pan; Shuang Guo; Yingjuan Liu; Yong Xiong; Wen Xie; Xinghua Long
Journal:  J Inflamm Res       Date:  2021-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.